Med. praxi. 2022;19(3):197-200 | DOI: 10.36290/med.2022.031

Chronic urticaria - differential diagnosis and therapy

MUDr. Eva Švarcová
Immunoflow, s. r. o., Praha

Chronic Urticaria (CU) is a skin disease based on the episodic appearance of urticarial lesions with or without angioedema, on most days of the week, for a period of six weeks or longer. The lesions wax and wane rapidly, usually within 24 hours. Chronic spontaneous urticaria occurs more frequently in patients with autoimmune disorders. Triggers such as medications, physical stimuli, and stress can be identified in 10 to 20% of cases. In diagnostics, the typical clinical features and the detailed anamnesis are the most helpful. Laboratory testing should include examination of C-reactive protein, erythrocyte sedimentation rate, complete blood count with differential, eventually IgG anti thyroperoxidase, and total IgE. The mainstay of therapy is patient education, avoidance of known triggers, and pharmacotherapy. Second-generation H1 antihistamines are the drugs of the first choice. If satisfactory improvement does not occur, the dose of antihistamines can be increased up to fourfold. For severe cases of chronic spontaneous urticaria is reserved the therapy with omalizumab.

Keywords: urticaria, angioedema, antihistamines.

Published: June 16, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Švarcová E. Chronic urticaria - differential diagnosis and therapy. Med. praxi. 2022;19(3):197-200. doi: 10.36290/med.2022.031.
Download citation

References

  1. Weller K, Altrichter S, Ardelean E, et al. Chronische Urtikaria. Prävalenz, Verlauf, Prognosefaktoren und Folgen [Chronic urticaria. Prevalence, course, prognostic factors and impact]. Hautarzt. 2010 Sep;61(9):750-7. German. doi: 10.1007/s00105-010-1933-8. PMID: 20694454. Go to original source... Go to PubMed...
  2. Kawauchi H, Yanai K, Wang DY, et al. Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties. Int J Mol Sci. 2019 Jan 8;20(1):213. doi: 10.3390/ijms20010213. PMID: 30626077; PMCID: PMC6337346. Go to original source... Go to PubMed...
  3. Fraser K, Robertson L. Chronic urticaria and autoimmunity. Skin Therapy Lett. 2013 Nov-Dec;18(7):5-9. PMID: 24305753.
  4. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA<sup>2</sup>LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022 Mar;77(3):734-766. doi: 10.1111/all.15090. Epub 2021 Oct 20. PMID: 34536239. Go to original source... Go to PubMed...
  5. Benáková N. Současné praktické postupy pro vyšetřování a léčbu chronické urtikárie, Aktualizovaný přehled a interpretace doporučených postupů pro praxi. Čes-slov Derm. 2015;90(5):198-212.
  6. Schaefer P. Acute and Chronic Urticaria: Evaluation and Treatment. Am Fam Physician. 2017 Jun 1;95(11):717-724. PMID: 28671445. Go to PubMed...
  7. Kaplan AP. Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria. Allergy Asthma Proc. 2018 May 1;39(3):184-190. doi: 10.2500/aap.2018.39.4121. PMID: 29669665. Go to original source... Go to PubMed...
  8. Sánchez J, Sánchez A, Cardona R. Causal Relationship Between Anti-TPO IgE and Chronic Urticaria by In Vitro and In Vivo Tests. Allergy Asthma Immunol Res. 2019 Jan;11(1): 29-42. doi: 10.4168/aair.2019.11.1.29. PMID: 30479075; PMCID: PMC6267185. Go to original source... Go to PubMed...
  9. Kolkhir P, Altrichter S, Munoz M, et al. New treatments for chronic urticaria. Ann Allergy Asthma Immunol. 2020 Jan;124(1):2-12. doi: 10.1016/j.anai.2019.08.014. Epub 2019 Aug 23. Erratum in: Ann Allergy Asthma Immunol. 2022 Feb;128(2):234. PMID: 31446134. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.